Urologische Klinik

TROPiCS-04: Study of sacituzumab govitecan in metastatic or locally advanced unresectable urothelial cancer that has progressed after platinum and checkpoint inhibitor therapy. (2021) Grivas P, Tagawa ST, Bellmunt J, De Santis M, Duran I, Goebell P, Necchi A, et al. Conference contribution Fortgeschrittenes Prostatakarzinom: Sequenz aus androgenrezeptorgerichteten Substanzen und Chemotherapie entscheidet über das Langzeitüberleben (2021) Wuelfing C, Goebell P, Eichenauer R, Lange C, Machtens S, Schwentner C, Todenhoefer T, et al. Journal article German Society of Residents in Urology (GeSRU) (2021) Siech C, Beck A, Fassbach M, Zehe , Wundrack F, Koenig J, Bellut L Journal article, Editorial Tert promoter mutation analysis of whole-organ mapping bladder cancers (2021) Weyerer V, Eckstein M, Strissel P, Wullweber A, Lange F, Tögel L, Geppert CI, et al. Journal article Immune Cell-Associated Protein Expression Helps to Predict Survival in Muscle-Invasive Urothelial Bladder Cancer Patients after Radical Cystectomy and Optional Adjuvant Chemotherapy (2021) Taubert H, Eckstein M, Epple E, Jung R, Weigelt K, Lieb V, Sikic D, et al. Journal article C-reactive protein flare-response predicts long-term efficacy to first-line anti-PD-1-based combination therapy in metastatic renal cell carcinoma (2021) Klumper N, Schmucker P, Hahn O, Hoh B, Mattigk A, Banek S, Ellinger J, et al. Journal article Correction to: Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases (Modern Pathology, (2021), 10.1038/s41379-021-00923-6) (2021) Farcaş M, Gatalica Z, Trpkov K, Swensen J, Zhou M, Alaghehbandan R, Williamson SR, et al. Journal article, Erratum Rational follow-up of non-muscle invasive bladder cancer Rationale Nachsorge des nicht-muskelinvasiven Harnblasenkarzinoms (2021) Von Landenberg N, Benderska-Soeder N, Bismarck E, Kernig K, Erne E, Goebell P, Schmitz-Draeger BJ Journal article, Review article Real-world treatment patterns in metastatic hormone-sensitive prostate cancer (mHSPC) patients in the US, Germany, France, China and Japan (2021) Goebell P, Shah R, Raina R, Rege S, Chen SL, Lee VE, Waldeck R Conference contribution The Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder Cancer (2021) Sikic D, Taubert H, Breyer J, Eckstein M, Weyerer V, Keck B, Kubon J, et al. Journal article